Pharmaceutical and medicine manufacturing government-funded R&D

Pharmaceuticals and medicines, 3254 125,986 empty 114,225 empty 11,761 empty 549 empty 2,104 empty 9,029 empty 79 empty

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

National Center for Science and Engineering Statistics. (2023). Business R&D Performance in the United States Increases to $722 Billion in 2023. Retrieved September 17, 2026, from https://ncses.nsf.gov/pubs/nsf25353. Via StatOrigin, https://statorigin.org/stat/stat_AN95JY586K083ZAY5TY48GEH6C

Copy

MLA

National Center for Science and Engineering Statistics. "Business R&D Performance in the United States Increases to $722 Billion in 2023." 2023, https://ncses.nsf.gov/pubs/nsf25353. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_AN95JY586K083ZAY5TY48GEH6C.

Copy

Chicago

National Center for Science and Engineering Statistics. "Business R&D Performance in the United States Increases to $722 Billion in 2023." 2023. https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_AN95JY586K083ZAY5TY48GEH6C.

Copy

BibTeX

@misc{ncses2023pharmaceutical8geh6c, author = {{National Center for Science and Engineering Statistics}}, title = {Business R\&D Performance in the United States Increases to \$722 Billion in 2023}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_AN95JY586K083ZAY5TY48GEH6C}, note = {Original source: https://ncses.nsf.gov/pubs/nsf25353. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_AN95JY586K083ZAY5TY48GEH6C.